Intensitymodulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial - Brand, D H; Tree, A C; Ostler, P (Lancet Oncol, 2019)